Here are four things to know:
1. The Subchondroplasty technology is used in minimally invasive outpatient interventions.
2. It aims to address the defects associated with subchondral bone marrow lesions.
3. Zimmer Biomet acquired the Subchondroplasty technology in 2013.
4. Zimmer Biomet now owns sixteen patents and eight trademarks in this area.
More articles on devices:
5 observations on Amedica shares dropping by 15.92%
Global MIS market to grow to $50B+ by 2019: 7 key trends
ExactechGPS launches globally: 5 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
